Cheon Yong-Pil, DeMayo Francesco J, Bagchi Milan K, Bagchi Indrani C
Department of Veterinary Biosciences, University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, USA.
J Biol Chem. 2004 Mar 12;279(11):10357-63. doi: 10.1074/jbc.M309434200. Epub 2003 Dec 16.
During early pregnancy, the steroid hormone progesterone induces differentiation of uterine stroma to decidual cells, which regulate embryo-uterine interactions. The progesterone-induced signaling molecules that participate in the formation and function of decidua remain poorly understood. We recently utilized high-density oligonucleotide microarrays to identify several genes whose expression is markedly altered in pregnant uterus in response to RU486, a well characterized antagonist of the progesterone receptor (PR). Our study revealed that the gene encoding cytotoxic T-lymphocyte antigen-2beta (CTLA-2beta), a cysteine protease inhibitor, is expressed during PR-induced decidualization. The spatio-temporal expression of CTLA-2beta mRNA precisely overlapped with the decidual phase of pregnancy. Interestingly, administration of progesterone to estrogen-primed ovariectomized mice failed to induce CTLA-2beta expression. A concomitant artificial decidual stimulation was necessary to trigger this expression. Uteri of PR knockout mice failed to express this mRNA, even after a combined administration of steroid hormones and artificial stimulation. The uterine expression of CTLA-2beta was, therefore, dependent on PR as well as other unknown factor(s) associated with decidual response. To identify the molecular target(s) of CTLA-2beta,we analyzed its interaction with proteins present in soluble extracts prepared from day 7 pregnant uteri containing implanted embryos. A protein affinity strategy employing recombinant CTLA-2beta helped us to determine that cathepsin L, a cysteine protease, is one of its targets in the pregnant uterus. Consistent with this finding, expression of cathepsin L was detected in the giant trophoblast cells of the ectoplacental cone on day 7 of pregnancy. Collectively, our results support the hypothesis that expression of CTLA-2beta in the decidua may regulate implantation of the embryo by neutralizing the activities of one or more proteases generated by the proliferating trophoblast.
在妊娠早期,甾体激素孕酮诱导子宫基质分化为蜕膜细胞,后者调节胚胎与子宫的相互作用。然而,参与蜕膜形成和功能的孕酮诱导信号分子仍知之甚少。我们最近利用高密度寡核苷酸微阵列来鉴定几个基因,其表达在妊娠子宫中因RU486(一种特征明确的孕酮受体拮抗剂)而发生显著改变。我们的研究表明,编码细胞毒性T淋巴细胞抗原-2β(CTLA-2β,一种半胱氨酸蛋白酶抑制剂)的基因在孕酮诱导的蜕膜化过程中表达。CTLA-2β mRNA的时空表达与妊娠的蜕膜期精确重叠。有趣的是,对雌激素预处理的去卵巢小鼠给予孕酮未能诱导CTLA-2β表达。需要同时进行人工蜕膜刺激才能触发这种表达。即使联合给予甾体激素和人工刺激,孕酮受体敲除小鼠的子宫仍未能表达这种mRNA。因此,CTLA-2β的子宫表达依赖于孕酮受体以及与蜕膜反应相关的其他未知因素。为了鉴定CTLA-2β的分子靶点,我们分析了它与从含有植入胚胎的妊娠第7天子宫制备的可溶性提取物中存在的蛋白质的相互作用。采用重组CTLA-2β的蛋白质亲和策略帮助我们确定,半胱氨酸蛋白酶组织蛋白酶L是其在妊娠子宫中的靶点之一。与这一发现一致,在妊娠第7天的外胎盘锥的巨大滋养层细胞中检测到了组织蛋白酶L的表达。总的来说,我们的结果支持这样一种假说,即蜕膜中CTLA-2β的表达可能通过中和增殖滋养层产生的一种或多种蛋白酶的活性来调节胚胎着床。